TNG Stock Overview
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for TNG from our risk checks.
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.57 |
| 52 Week High | HK$1.00 |
| 52 Week Low | HK$0.55 |
| Beta | 1.04 |
| 1 Month Change | -1.71% |
| 3 Month Change | -18.44% |
| 1 Year Change | -36.81% |
| 3 Year Change | -10.85% |
| 5 Year Change | -52.52% |
| Change since IPO | -53.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| TNG | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 5.5% | 3.2% | 1.7% |
| 1Y | -36.8% | -28.2% | 2.3% |
Return vs Industry: TNG underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: TNG underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| TNG volatility | |
|---|---|
| TNG Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TNG's share price has been volatile over the past 3 months.
Volatility Over Time: TNG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 4,030 | Jia Fu Chen | www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
| TNG fundamental statistics | |
|---|---|
| Market cap | €736.36m |
| Earnings (TTM) | €76.05m |
| Revenue (TTM) | €872.84m |
9.7x
P/E Ratio0.8x
P/S RatioIs TNG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TNG income statement (TTM) | |
|---|---|
| Revenue | CN¥6.77b |
| Cost of Revenue | CN¥3.93b |
| Gross Profit | CN¥2.85b |
| Other Expenses | CN¥2.26b |
| Earnings | CN¥590.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 42.04% |
| Net Profit Margin | 8.71% |
| Debt/Equity Ratio | 15.1% |
How did TNG perform over the long term?
See historical performance and comparison